BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

MLA

Hanne Meijers-Heijboer, et al. “BRCA1 Genomic Deletions Are Major Founder Mutations in Dutch Breast Cancer Patients.” Nature Genetics, vol. 17, Nov. 1997, pp. 341–45. EBSCOhost, https://doi.org/10.1038/ng1197-341.

APA

Hanne Meijers-Heijboer, Egbert Bakker, M.J.L. Ligtenberg, Anne Petrij-Bosch, Tamara Peelen, M. Drusedau, Cees J. Cornelisse, R. Olmer, Peter Devilee, S. Hageman, Hans F. A. Vasen, L.J. van ’t Veer, Jan G. M. Klijn, G.J.B. van Ommen, Frans B. L. Hogervorst, Peer Arts, M. van Vliet, & R. van Eijk. (1997). BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nature Genetics, 17, 341–345. https://doi.org/10.1038/ng1197-341

Chicago

Hanne Meijers-Heijboer, Egbert Bakker, M.J.L. Ligtenberg, Anne Petrij-Bosch, Tamara Peelen, M. Drusedau, Cees J. Cornelisse, et al. 1997. “BRCA1 Genomic Deletions Are Major Founder Mutations in Dutch Breast Cancer Patients.” Nature Genetics 17 (November): 341–45. doi:10.1038/ng1197-341.